GlassScriptPhysician profile
Kendra M Breithaupt
NPI 1942454632
$620.38
in general payments reported to CMS, 2019-2025
13 companies · $271 in 2025
The $271 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $79.41 · 2022: $149 · 2023: $97.64 · 2024: $23.72 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $391.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $149.72 | 2021-2025 | |
| Novo Nordisk INC | $122.30 | 2021-2025 | Wegovy, Saxenda, Rybelsus |
| Pfizer INC. | $64.94 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $60.78 | 2025 | Invega Sustenna, Spravato |
| Recor Medical INC | $41.13 | 2025 | Paradise Ultrasound Renal Denervation System |
| Galderma Laboratories, L.P. | $28.99 | 2021-2022 | |
| Lilly USA, LLC | $28.42 | 2022-2025 | Zepbound, Mounjaro |
| Inspire Medical Systems, INC. | $25.83 | 2025 | Inspire |
| Corcept Therapeutics | $24.78 | 2025 | Korlym |
| Biohaven Pharmaceutical Holding Company LTD. | $23.92 | 2022 | |
| Genentech USA, INC. | $18.45 | 2021 | |
| Antares Pharma, INC. | $15.93 | 2023 | Nocdurna, Xyosted, Tlando |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendra Breithaupt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.